Royce & Associates’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,510
| Closed | -$163K | – | 1262 |
|
|
2018
Q1 | $163K | Buy |
1,510
+6
| +0.4% | +$648 | ﹤0.01% | 1094 |
|
|
2017
Q4 | $447K | Buy |
1,504
+417
| +38% | +$124K | ﹤0.01% | 1048 |
|
|
2017
Q3 | $258K | Buy |
1,087
+254
| +30% | +$60.3K | ﹤0.01% | 1061 |
|
|
2017
Q2 | $441K | Buy |
833
+689
| +478% | +$365K | ﹤0.01% | 1044 |
|
|
2017
Q1 | $78K | Buy |
+144
| New | +$78K | ﹤0.01% | 1102 |
|
|
2016
Q4 | – | Sell |
-582
| Closed | -$363K | – | 1112 |
|
|
2016
Q3 | $363K | Sell |
582
-125
| -18% | -$78K | ﹤0.01% | 1017 |
|
|
2016
Q2 | $443K | Sell |
707
-125
| -15% | -$78.3K | ﹤0.01% | 1000 |
|
|
2016
Q1 | $617K | Buy |
+832
| New | +$617K | ﹤0.01% | 966 |
|